InvestorsHub Logo
Followers 12
Posts 1226
Boards Moderated 1
Alias Born 08/16/2009

Re: halpern6 post# 3

Sunday, 01/31/2010 3:53:25 PM

Sunday, January 31, 2010 3:53:25 PM

Post# of 18
No problem... Their drug is for a $600M market. ~60.4M shares outstanding, could hit $10 w/ an advisory committee vote in favor of approval, IMO.


Visit my biotech investing board!: